[go: up one dir, main page]

WO2006005017A3 - Composition orale contenant un agent carbamoylant - Google Patents

Composition orale contenant un agent carbamoylant Download PDF

Info

Publication number
WO2006005017A3
WO2006005017A3 PCT/US2005/023624 US2005023624W WO2006005017A3 WO 2006005017 A3 WO2006005017 A3 WO 2006005017A3 US 2005023624 W US2005023624 W US 2005023624W WO 2006005017 A3 WO2006005017 A3 WO 2006005017A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral composition
carbamylating agent
agent
carbamylating
diluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/023624
Other languages
English (en)
Other versions
WO2006005017A2 (fr
Inventor
Jekone Zsuzsanna Bentzil
Sabine Gutman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant Research and Development
Original Assignee
Valeant Research and Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valeant Research and Development filed Critical Valeant Research and Development
Publication of WO2006005017A2 publication Critical patent/WO2006005017A2/fr
Publication of WO2006005017A3 publication Critical patent/WO2006005017A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne des compositions administrées par voie orale à libération rapide contenant un agent carbamoylant tel qu'un bromure de pyridostigmine, un agent hydrophobe et un diluant, ainsi que les procédés d'administration et de préparation de telles compositions.
PCT/US2005/023624 2004-06-30 2005-06-30 Composition orale contenant un agent carbamoylant Ceased WO2006005017A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58434904P 2004-06-30 2004-06-30
US60/584,349 2004-06-30

Publications (2)

Publication Number Publication Date
WO2006005017A2 WO2006005017A2 (fr) 2006-01-12
WO2006005017A3 true WO2006005017A3 (fr) 2006-04-20

Family

ID=35783388

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/023624 Ceased WO2006005017A2 (fr) 2004-06-30 2005-06-30 Composition orale contenant un agent carbamoylant

Country Status (2)

Country Link
TW (1) TW200706173A (fr)
WO (1) WO2006005017A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2356984A1 (fr) * 2010-02-04 2011-08-17 Nycomed Austria GmbH Formulation améliorée de bromure de distigmine
US20200054611A1 (en) 2017-01-09 2020-02-20 Gt Biopharma, Inc. Use and composition for treating myasthenia gravis and other myasthenic syndromes
WO2019023318A1 (fr) 2017-07-25 2019-01-31 Gt Biopharma, Inc. Compositions pharmaceutiques et procédés utilisant de la pyridostigmine et un antagoniste de nk-1 pour traiter la myasthénie grave
WO2019023175A1 (fr) * 2017-07-25 2019-01-31 Gt Biopharma, Inc. Compositions pharmaceutiques et procédés d'utilisation et de néostigmine et d'un antagoniste nk-1 pour le traitement de la myasthénie grave

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
US FOOD AND DRUG ADMINISTRATION, CENTER FOR DRUG EVALUATION AND RESEARCH, 5 February 2003 (2003-02-05), Retrieved from the Internet <URL:http://www.fda.gov/cder/drg/infopage/Pyridostigmine_Bromide/Q&A.htm> *

Also Published As

Publication number Publication date
WO2006005017A2 (fr) 2006-01-12
TW200706173A (en) 2007-02-16

Similar Documents

Publication Publication Date Title
WO2006069363A3 (fr) Formes cristallines d&#39;hydrochlorure de (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
WO2008064353A3 (fr) Analogues 4,5-époxy-morphinanium saturé en position 7 et 8
WO2007090393A3 (fr) Préparation pharmaceutique
WO2007120980A3 (fr) Composés de 2,4-pyrimidinediamine pour le traitement ou la prévention de maladies autoimmunes
WO2005070090A3 (fr) Lymphocytes t regulateurs supprimant l&#39;auto-immunite
WO2007019439A3 (fr) Compositions de copolymere sequence et utilisations de ces dernieres
WO2007077560A3 (fr) Compositions cryoprotectrices et procédés d&#39;utilisation de celles-ci
WO2004014322A3 (fr) Compositions immunomodulatrices, leurs methodes de preparation et utilisation
WO2004082822A3 (fr) Procedes permettant d&#39;isoler la forme i cristalline de la 5-azacytidine
WO2008009379A3 (fr) Associations de principes actifs présentant des propriétés insecticides et acaricides
WO2003095455A3 (fr) Composes therapeutiques
WO2008013840A3 (fr) Analogues de l&#39;érastine et leurs utilisations
WO2004069152A3 (fr) ?4,5 glycuronidase et ses utilisations
WO2006114520A3 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
WO2004091645A3 (fr) Composition d&#39;acide de romarin
WO2006024479A3 (fr) Compositions pharmaceutiques
WO2005112633A3 (fr) Composes et compositions pour administration d’agents actifs
WO2004093800A3 (fr) Derives de thyronamine et analogues et des methodes d&#39;utilisation de ces composes
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
WO2008073863A3 (fr) Préparation et utilité d&#39;allylamines substituées
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
IL182811A (en) History of dicarboxamide preparations, uses and methods for their preparation
WO2006056695A8 (fr) Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
WO2006005017A3 (fr) Composition orale contenant un agent carbamoylant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase